Chromadex Awarded Antioxidant Research Grant

IRVINE, Calif.ChromaDex Corp. announced today that the National Science Foundation awarded the company a $100,000 Small Business Innovation Research (SBIR) Grant to further the development of several plant-based antioxidants for commercial use in pharmaceutical, nutraceutical, functional food, natural chemical and cosmetic products.
The project, entitled "SBIR Phase I: Microbial Production of Selected Anthocyanins," will prove the viability of selectively manufacturing anthocyanins, leucoanthocyanidins and anthocyanidins. These compounds are naturally occurring pigments and antioxidants that can be used as natural colorants, possibly aid in controlling blood glucose levels to assist with weight management and diabetes, and provide similar benefits to the hotly discussed superfruit compound found in red wine, resveratrol.
We are honored to have our work recognized by the National Science Foundation in the form of a research award, said Frank Jaksch, co-founder and CEO of ChromaDex. This is the first step in validating the production of these anthocyanins, and based on the success of this research, we look forward to driving this technology toward commercialization.